Skip to Content
Merck
CN

C8289

Clebopride maleate salt

~95%

Synonym(s):

4-(4-Amino-5-chloro-2-methoxybenzamido)-1-benzylpiperidine

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C20H24ClN3O2 · C4H4O4
CAS Number:
Molecular Weight:
489.95
UNSPSC Code:
51101500
PubChem Substance ID:
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

~95%

storage temp.

2-8°C

SMILES string

OC(=O)\C=C\C(O)=O.COc1cc(N)c(Cl)cc1C(=O)NC2CCN(CC2)Cc3ccccc3

InChI

1S/C20H24ClN3O2.C4H4O4/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14;5-3(6)1-2-4(7)8/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25);1-2H,(H,5,6)(H,7,8)/b;2-1+

InChI key

BCVIWCRZYPHHMQ-WLHGVMLRSA-N



Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Related Content

Product Information Sheet


Domenico Bosco et al.
Clinical neuropharmacology, 32(2), 107-108 (2009-06-11)
Dystonic reactions produce twisting and repetitive movements or abnormal posturing. Severe dystonic reactions have been shown to occur in concert with numerous medications. This report details the case of a patient who developed hemifacial dystonia as acute side reaction from
[Acute laryngeal dystonia due to clebopride simulating allergic reaction].
Mercè Corominas Sánchez et al.
Medicina clinica, 129(6), 238-239 (2007-08-07)
Jaume Campdelacreu et al.
Movement disorders : official journal of the Movement Disorder Society, 19(4), 482-484 (2004-04-13)
We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is